0 views
mesothelioma , Mesothelioma: What is Immunotherapy? , , R89CnAFM3r4 , , https://i.ytimg.com/vi/R89CnAFM3r4/hqdefault.jpg , 292 , , Experts from the Penn Mesothelioma and Pleural Program discuss the role of immunotherapy (using the body’s immune system to fight against cancerous cells and other diseases to heal itself) in treating mesothelioma. , 1406914489 , 2014-08-01 10:34:49 , 00:02:10 , UC36Nlm8ikeZ4tDRx__BjJnA , , 0 , , 3708395929001,destroy-cancer,suppress-cancer,biotherapy,treatment-options,immunotherapy,biological-therapy,mesothelioma,Penn-Medicine,YT,cure-is-within,immune-system , #Mesothelioma #Immunotherapy
Date: May 7, 2023
Immunotherapy is a promising approach to treating mesothelioma, according to experts from the Penn Mesothelioma and Pleural Program. The treatment works by activating the body's immune system to recognize and attack cancer cells. This is particularly important in mesothelioma, as it is known to be resistant to traditional chemotherapy and radiation therapy.
One type of immunotherapy that is currently being studied for mesothelioma is checkpoint inhibitors. These drugs work by blocking certain proteins on cancer cells that prevent the immune system from attacking them. By blocking these proteins, checkpoint inhibitors can help the immune system to recognize and attack the cancer cells.
Another approach to immunotherapy for mesothelioma is the use of adoptive T-cell therapy. This involves removing T-cells (a type of immune cell) from a patient's body, modifying them in the lab to specifically recognize and attack cancer cells, and then reintroducing them into the patient's body. This approach has shown promise in early studies, but more research is needed to determine its effectiveness.
Immunotherapy is an exciting area of research for mesothelioma treatment, and ongoing clinical trials are exploring its potential to improve outcomes for patients with this rare and aggressive cancer.